Serine supplementation: Is it a new option for the treatment of diabetic polyneuropathy?
Journal of Diabetes Investigation · 2023
DOI: 10.1111/jdi.14047 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of Diabetes Investigation, 2023. Verfasst von Hiroki Mizukami. Beteiligte Einrichtung: Department of Pathology and Molecular Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Diabetes Mellitus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Molecular Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
ORCID-Profile: Hiroki Mizukami
Zitieren
APA
Mizukami, H. (2023). Serine supplementation: Is it a new option for the treatment of diabetic polyneuropathy?. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.14047
Vancouver
Mizukami H. Serine supplementation: Is it a new option for the treatment of diabetic polyneuropathy?. Journal of Diabetes Investigation. 2023. doi:10.1111/jdi.14047
BibTeX
@article{Mizukami2023,
author = {Mizukami, Hiroki},
title = {Serine supplementation: Is it a new option for the treatment of diabetic polyneuropathy?},
journal = {Journal of Diabetes Investigation},
year = {2023},
doi = {10.1111/jdi.14047}
}
EUVIMED